Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.

STOCKHOLM & RADNOR, Pa.— Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today announced that they have entered into an agreement and plan of merger under which Immedica has agreed to acquire Marinus, by means of a tender offer and subsequent merger.

SSR Mining Celebrates 5 Million Ounces of Gold Production From Marigold

DENVER — SSR Mining Inc. (Nasdaq/TSX: SSRM, ASX: SSR) (“SSR Mining” or the “Company”) is pleased to announce that the Marigold Mine achieved 5 million ounces of gold production on December 30, 2024. Marigold has been in continuous operation for more than 35 years and has produced more than 2 million ounces of gold since its acquisition by SSR Mining in 2014, including a record 278,000 ounces of gold production in 2023.

error: Content is protected !!